White paper · January 2026
Strategic Entry into China's Dental Market
A disciplined, risk-controlled guide for European dental companies facing a USD 22 bn market that is growing near 10% a year — and that is unforgiving about sequence.
What is inside
- Market structure by city tier, clinic type and purchasing power
- Why nearly 90% of 140,000 clinics being private changes the channel question
- Distributor models, and how brands lose control of pricing and registration
- NMPA pathway design aligned with commercial strategy, not run ahead of it
- Pricing and positioning validation with clinics and DSOs
- A three-phase entry framework, from pilot to national scale-up
Built on direct engagement with dentists, KOLs and dental groups across China. Written to support internal strategy and investment decisions — not as promotional content.
Or skip the paper
Thirty minutes is usually faster than forty pages.
Entering China's dental market is a CEO-level decision with consequences that are hard to unwind inside eighteen to twenty-four months. A focused discussion clarifies feasibility and sequencing before capital is committed.